Investor mix
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 50% |
| Private equity | 1 | 50% |
Develops proprietary technologies for laser based in-situ synthesis of oligonucleotides
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 50% |
| Private equity | 1 | 50% |